NEW YORK (GenomeWeb) – Personal Genome Diagnostics said today that it has raised $75 million in a Series B financing round led by new investor Bristol-Myers Squibb and previous investor New Enterprise Associates.

New and existing investors including Inova Strategic Investments, Co-win Healthcare Fund, Helsinn Investment Fund, Windham Venture Partners, and Maryland Venture Fund participated in the financing along with undisclosed investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.